Thursday April 1
...
| Time | Item | Who |
|---|---|---|
| 2 min | Welcome & Antitrust Policy Notice | Chair & PM |
| 5 min | Introductions | Chair & PM |
| 5 min | Backgrounder | Chair |
| + | Open Discussion | Group |
| 2 min | Wrap up | Chair & PM |
Meeting Notes
- [Darrell] Anti-trust and membership policy introduction
- [Todd] Work at this group and GHP was reflected in conversations at the WHO call of 31Mar
- Key interoperability questions - [Darrell] some opening remarks on the topic of trust registries as a solution and where they fit in (are they a solution or a challenge?)
- Is there a way to establish transitive trust between different parts of the GHP digital trust ecosystem
- [Todd] establishing a globally scalable, jurisdiction specific registry is a challenge eg. X.509 trust registries - how do we work with those?
- [Darrell] analogy of lanes/queues to describe the nub of the issue
- [Julian] ‘who is being registered in these registry’ - assumption is people making the tests and vaccines (this massive trust registry is impossible) a short term solution is that the people who provide the trust (the app providers) provide it directly when presenting credentials.
...
Steve Magennis : I believe items 5-11 below is where our focus needs to be and where we can offer real value. Items 1-4 are deep, complex issues that need to be resolved well in advance of the actual act of verification. These decisions will almost certainly be fluid and driven by a complicated mix of policy makers, corporate lawyers, industry advocates, public health professionals and public opinion.Anchor Steve-Magennis Steve-Magennis
...